UN Human Rights Council’s Resolution on Access to Medicines and Vaccines Welcomed by Civil Society 11/07/2022 Elaine Ruth Fletcher Citizens and NGOs welcomed the United Nations Human Rights Council’s adoption of a much-debated draft resolution that calls on nations to ensure everyone has access to medicines and vaccines. The resolution was adopted by consensus Friday shortly before the close of the HRC’s 50th session, sending what proponents called a “clear message” that access to […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> WTO Agrees on Limited IP Waiver for COVID-19 Vaccines and Package to Reduce Harmful Fishing Subsidies 17/06/2022 John Heilprin & Elaine Ruth Fletcher Limited IP waiver text says WTO members “will decide” on inclusion of COVID-19 tests and treatments within six months. The World Trade Organization’s first ministerial conference in four and a half years reached agreement early Friday morning on what officials described as “an unprecedented outcome” of six agreements, including a deal to curb some fishing […] Continue reading -> WTO Ministerial Conference Extended for Another Day as Pressure Builds for Results 15/06/2022 John Heilprin & Elaine Ruth Fletcher The World Trade Organization (WTO) is extending its 12th Ministerial Conference (MC12) for a fifth day, buying time for delegates to negotiate some tough deals in five main areas: the pandemic response, COVID-19 vaccines, fishing subsidies, food shortages and agriculture. The long-delayed ministerial conference, which opened on Sunday and was originally planned to close on […] Continue reading -> WTO Opens with Note of ‘Cautious Optimism’ on Prospects for Agreement over Fisheries Subsidies and COVID Vaccine IP Waiver 12/06/2022 Elaine Ruth Fletcher The World Trade Organization’s Director General Dr Ngozi Okonjo Iweala said she was “cautiously optimistic” about the potential for WTO members to reach long-delayed agreements on issues such as a limited IP waiver for COVID vaccines as well as a decision to curb harmful fisheries subsidies that allow big industrial rigs to plunder the oceans […] Continue reading -> One In Three People Globally Need Assistive Technologies; ‘Stunning Disparity’ In Access 16/05/2022 Aishwarya Tendolkar From wheelchairs to memory aids, over 2.5 billion people in the world today need at least one assistive device either for communication, vision, mobility, as well as for certain cognitive functions, like memory aids. And the number is set to rise to 3.5 billion people by 2050 due to an ageing population and the prevalence […] Continue reading -> WTO Chief Hopes for “Workable Compromise” on TRIPS Waiver by June; US Signs Deal to Share COVID Vaccine Know-How with WHO 12/05/2022 Raisa Santos & Elaine Ruth Fletcher The United States National Institute of Health (NIH) has finalized an agreement with WHO’s COVID-19 patent sharing facility (C-TAP) to share the patent rights on 11 government-funded coronavirus medicine and vaccine technologies – in what is perhaps the most significant agreement to date with WHO to share closely-guarded pharma know-how. The announcement was made today […] Continue reading -> Moderna Seeks Dismissal in US Court of COVID-19 Vaccine Patent Infringement Lawsuit By Arbutus, Genevant 11/05/2022 Aishwarya Tendolkar Moderna has filed a brief in the United States District Court for the District of Delaware seeking the dismissal of a patent infringement lawsuit that pertains to the production and sale of its COVID-19 mRNA vaccine Spikevax. The lawsuit against the U.S-based pharmaceutical giant was filed by Arbutus Biopharma Corporation and Genevant Sciences, which had […] Continue reading -> After Months of Deadlock, WTO’s TRIPS Council Will Finally Discuss Intellectual Property Waiver Compromise 03/05/2022 Kerry Cullinan In a significant breakthrough, the World Trade Organization’s (WTO) TRIPS Council on Friday will finally discuss a compromise proposal on a waiver of intellectual property (IP) rights on COVID-19 vaccines – almost 18 months after it was first proposed by India and South Africa. Members attending an informal meeting of the TRIPS Council on Tuesday […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> WTO Agrees on Limited IP Waiver for COVID-19 Vaccines and Package to Reduce Harmful Fishing Subsidies 17/06/2022 John Heilprin & Elaine Ruth Fletcher Limited IP waiver text says WTO members “will decide” on inclusion of COVID-19 tests and treatments within six months. The World Trade Organization’s first ministerial conference in four and a half years reached agreement early Friday morning on what officials described as “an unprecedented outcome” of six agreements, including a deal to curb some fishing […] Continue reading -> WTO Ministerial Conference Extended for Another Day as Pressure Builds for Results 15/06/2022 John Heilprin & Elaine Ruth Fletcher The World Trade Organization (WTO) is extending its 12th Ministerial Conference (MC12) for a fifth day, buying time for delegates to negotiate some tough deals in five main areas: the pandemic response, COVID-19 vaccines, fishing subsidies, food shortages and agriculture. The long-delayed ministerial conference, which opened on Sunday and was originally planned to close on […] Continue reading -> WTO Opens with Note of ‘Cautious Optimism’ on Prospects for Agreement over Fisheries Subsidies and COVID Vaccine IP Waiver 12/06/2022 Elaine Ruth Fletcher The World Trade Organization’s Director General Dr Ngozi Okonjo Iweala said she was “cautiously optimistic” about the potential for WTO members to reach long-delayed agreements on issues such as a limited IP waiver for COVID vaccines as well as a decision to curb harmful fisheries subsidies that allow big industrial rigs to plunder the oceans […] Continue reading -> One In Three People Globally Need Assistive Technologies; ‘Stunning Disparity’ In Access 16/05/2022 Aishwarya Tendolkar From wheelchairs to memory aids, over 2.5 billion people in the world today need at least one assistive device either for communication, vision, mobility, as well as for certain cognitive functions, like memory aids. And the number is set to rise to 3.5 billion people by 2050 due to an ageing population and the prevalence […] Continue reading -> WTO Chief Hopes for “Workable Compromise” on TRIPS Waiver by June; US Signs Deal to Share COVID Vaccine Know-How with WHO 12/05/2022 Raisa Santos & Elaine Ruth Fletcher The United States National Institute of Health (NIH) has finalized an agreement with WHO’s COVID-19 patent sharing facility (C-TAP) to share the patent rights on 11 government-funded coronavirus medicine and vaccine technologies – in what is perhaps the most significant agreement to date with WHO to share closely-guarded pharma know-how. The announcement was made today […] Continue reading -> Moderna Seeks Dismissal in US Court of COVID-19 Vaccine Patent Infringement Lawsuit By Arbutus, Genevant 11/05/2022 Aishwarya Tendolkar Moderna has filed a brief in the United States District Court for the District of Delaware seeking the dismissal of a patent infringement lawsuit that pertains to the production and sale of its COVID-19 mRNA vaccine Spikevax. The lawsuit against the U.S-based pharmaceutical giant was filed by Arbutus Biopharma Corporation and Genevant Sciences, which had […] Continue reading -> After Months of Deadlock, WTO’s TRIPS Council Will Finally Discuss Intellectual Property Waiver Compromise 03/05/2022 Kerry Cullinan In a significant breakthrough, the World Trade Organization’s (WTO) TRIPS Council on Friday will finally discuss a compromise proposal on a waiver of intellectual property (IP) rights on COVID-19 vaccines – almost 18 months after it was first proposed by India and South Africa. Members attending an informal meeting of the TRIPS Council on Tuesday […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WTO Agrees on Limited IP Waiver for COVID-19 Vaccines and Package to Reduce Harmful Fishing Subsidies 17/06/2022 John Heilprin & Elaine Ruth Fletcher Limited IP waiver text says WTO members “will decide” on inclusion of COVID-19 tests and treatments within six months. The World Trade Organization’s first ministerial conference in four and a half years reached agreement early Friday morning on what officials described as “an unprecedented outcome” of six agreements, including a deal to curb some fishing […] Continue reading -> WTO Ministerial Conference Extended for Another Day as Pressure Builds for Results 15/06/2022 John Heilprin & Elaine Ruth Fletcher The World Trade Organization (WTO) is extending its 12th Ministerial Conference (MC12) for a fifth day, buying time for delegates to negotiate some tough deals in five main areas: the pandemic response, COVID-19 vaccines, fishing subsidies, food shortages and agriculture. The long-delayed ministerial conference, which opened on Sunday and was originally planned to close on […] Continue reading -> WTO Opens with Note of ‘Cautious Optimism’ on Prospects for Agreement over Fisheries Subsidies and COVID Vaccine IP Waiver 12/06/2022 Elaine Ruth Fletcher The World Trade Organization’s Director General Dr Ngozi Okonjo Iweala said she was “cautiously optimistic” about the potential for WTO members to reach long-delayed agreements on issues such as a limited IP waiver for COVID vaccines as well as a decision to curb harmful fisheries subsidies that allow big industrial rigs to plunder the oceans […] Continue reading -> One In Three People Globally Need Assistive Technologies; ‘Stunning Disparity’ In Access 16/05/2022 Aishwarya Tendolkar From wheelchairs to memory aids, over 2.5 billion people in the world today need at least one assistive device either for communication, vision, mobility, as well as for certain cognitive functions, like memory aids. And the number is set to rise to 3.5 billion people by 2050 due to an ageing population and the prevalence […] Continue reading -> WTO Chief Hopes for “Workable Compromise” on TRIPS Waiver by June; US Signs Deal to Share COVID Vaccine Know-How with WHO 12/05/2022 Raisa Santos & Elaine Ruth Fletcher The United States National Institute of Health (NIH) has finalized an agreement with WHO’s COVID-19 patent sharing facility (C-TAP) to share the patent rights on 11 government-funded coronavirus medicine and vaccine technologies – in what is perhaps the most significant agreement to date with WHO to share closely-guarded pharma know-how. The announcement was made today […] Continue reading -> Moderna Seeks Dismissal in US Court of COVID-19 Vaccine Patent Infringement Lawsuit By Arbutus, Genevant 11/05/2022 Aishwarya Tendolkar Moderna has filed a brief in the United States District Court for the District of Delaware seeking the dismissal of a patent infringement lawsuit that pertains to the production and sale of its COVID-19 mRNA vaccine Spikevax. The lawsuit against the U.S-based pharmaceutical giant was filed by Arbutus Biopharma Corporation and Genevant Sciences, which had […] Continue reading -> After Months of Deadlock, WTO’s TRIPS Council Will Finally Discuss Intellectual Property Waiver Compromise 03/05/2022 Kerry Cullinan In a significant breakthrough, the World Trade Organization’s (WTO) TRIPS Council on Friday will finally discuss a compromise proposal on a waiver of intellectual property (IP) rights on COVID-19 vaccines – almost 18 months after it was first proposed by India and South Africa. Members attending an informal meeting of the TRIPS Council on Tuesday […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WTO Ministerial Conference Extended for Another Day as Pressure Builds for Results 15/06/2022 John Heilprin & Elaine Ruth Fletcher The World Trade Organization (WTO) is extending its 12th Ministerial Conference (MC12) for a fifth day, buying time for delegates to negotiate some tough deals in five main areas: the pandemic response, COVID-19 vaccines, fishing subsidies, food shortages and agriculture. The long-delayed ministerial conference, which opened on Sunday and was originally planned to close on […] Continue reading -> WTO Opens with Note of ‘Cautious Optimism’ on Prospects for Agreement over Fisheries Subsidies and COVID Vaccine IP Waiver 12/06/2022 Elaine Ruth Fletcher The World Trade Organization’s Director General Dr Ngozi Okonjo Iweala said she was “cautiously optimistic” about the potential for WTO members to reach long-delayed agreements on issues such as a limited IP waiver for COVID vaccines as well as a decision to curb harmful fisheries subsidies that allow big industrial rigs to plunder the oceans […] Continue reading -> One In Three People Globally Need Assistive Technologies; ‘Stunning Disparity’ In Access 16/05/2022 Aishwarya Tendolkar From wheelchairs to memory aids, over 2.5 billion people in the world today need at least one assistive device either for communication, vision, mobility, as well as for certain cognitive functions, like memory aids. And the number is set to rise to 3.5 billion people by 2050 due to an ageing population and the prevalence […] Continue reading -> WTO Chief Hopes for “Workable Compromise” on TRIPS Waiver by June; US Signs Deal to Share COVID Vaccine Know-How with WHO 12/05/2022 Raisa Santos & Elaine Ruth Fletcher The United States National Institute of Health (NIH) has finalized an agreement with WHO’s COVID-19 patent sharing facility (C-TAP) to share the patent rights on 11 government-funded coronavirus medicine and vaccine technologies – in what is perhaps the most significant agreement to date with WHO to share closely-guarded pharma know-how. The announcement was made today […] Continue reading -> Moderna Seeks Dismissal in US Court of COVID-19 Vaccine Patent Infringement Lawsuit By Arbutus, Genevant 11/05/2022 Aishwarya Tendolkar Moderna has filed a brief in the United States District Court for the District of Delaware seeking the dismissal of a patent infringement lawsuit that pertains to the production and sale of its COVID-19 mRNA vaccine Spikevax. The lawsuit against the U.S-based pharmaceutical giant was filed by Arbutus Biopharma Corporation and Genevant Sciences, which had […] Continue reading -> After Months of Deadlock, WTO’s TRIPS Council Will Finally Discuss Intellectual Property Waiver Compromise 03/05/2022 Kerry Cullinan In a significant breakthrough, the World Trade Organization’s (WTO) TRIPS Council on Friday will finally discuss a compromise proposal on a waiver of intellectual property (IP) rights on COVID-19 vaccines – almost 18 months after it was first proposed by India and South Africa. Members attending an informal meeting of the TRIPS Council on Tuesday […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WTO Opens with Note of ‘Cautious Optimism’ on Prospects for Agreement over Fisheries Subsidies and COVID Vaccine IP Waiver 12/06/2022 Elaine Ruth Fletcher The World Trade Organization’s Director General Dr Ngozi Okonjo Iweala said she was “cautiously optimistic” about the potential for WTO members to reach long-delayed agreements on issues such as a limited IP waiver for COVID vaccines as well as a decision to curb harmful fisheries subsidies that allow big industrial rigs to plunder the oceans […] Continue reading -> One In Three People Globally Need Assistive Technologies; ‘Stunning Disparity’ In Access 16/05/2022 Aishwarya Tendolkar From wheelchairs to memory aids, over 2.5 billion people in the world today need at least one assistive device either for communication, vision, mobility, as well as for certain cognitive functions, like memory aids. And the number is set to rise to 3.5 billion people by 2050 due to an ageing population and the prevalence […] Continue reading -> WTO Chief Hopes for “Workable Compromise” on TRIPS Waiver by June; US Signs Deal to Share COVID Vaccine Know-How with WHO 12/05/2022 Raisa Santos & Elaine Ruth Fletcher The United States National Institute of Health (NIH) has finalized an agreement with WHO’s COVID-19 patent sharing facility (C-TAP) to share the patent rights on 11 government-funded coronavirus medicine and vaccine technologies – in what is perhaps the most significant agreement to date with WHO to share closely-guarded pharma know-how. The announcement was made today […] Continue reading -> Moderna Seeks Dismissal in US Court of COVID-19 Vaccine Patent Infringement Lawsuit By Arbutus, Genevant 11/05/2022 Aishwarya Tendolkar Moderna has filed a brief in the United States District Court for the District of Delaware seeking the dismissal of a patent infringement lawsuit that pertains to the production and sale of its COVID-19 mRNA vaccine Spikevax. The lawsuit against the U.S-based pharmaceutical giant was filed by Arbutus Biopharma Corporation and Genevant Sciences, which had […] Continue reading -> After Months of Deadlock, WTO’s TRIPS Council Will Finally Discuss Intellectual Property Waiver Compromise 03/05/2022 Kerry Cullinan In a significant breakthrough, the World Trade Organization’s (WTO) TRIPS Council on Friday will finally discuss a compromise proposal on a waiver of intellectual property (IP) rights on COVID-19 vaccines – almost 18 months after it was first proposed by India and South Africa. Members attending an informal meeting of the TRIPS Council on Tuesday […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
One In Three People Globally Need Assistive Technologies; ‘Stunning Disparity’ In Access 16/05/2022 Aishwarya Tendolkar From wheelchairs to memory aids, over 2.5 billion people in the world today need at least one assistive device either for communication, vision, mobility, as well as for certain cognitive functions, like memory aids. And the number is set to rise to 3.5 billion people by 2050 due to an ageing population and the prevalence […] Continue reading -> WTO Chief Hopes for “Workable Compromise” on TRIPS Waiver by June; US Signs Deal to Share COVID Vaccine Know-How with WHO 12/05/2022 Raisa Santos & Elaine Ruth Fletcher The United States National Institute of Health (NIH) has finalized an agreement with WHO’s COVID-19 patent sharing facility (C-TAP) to share the patent rights on 11 government-funded coronavirus medicine and vaccine technologies – in what is perhaps the most significant agreement to date with WHO to share closely-guarded pharma know-how. The announcement was made today […] Continue reading -> Moderna Seeks Dismissal in US Court of COVID-19 Vaccine Patent Infringement Lawsuit By Arbutus, Genevant 11/05/2022 Aishwarya Tendolkar Moderna has filed a brief in the United States District Court for the District of Delaware seeking the dismissal of a patent infringement lawsuit that pertains to the production and sale of its COVID-19 mRNA vaccine Spikevax. The lawsuit against the U.S-based pharmaceutical giant was filed by Arbutus Biopharma Corporation and Genevant Sciences, which had […] Continue reading -> After Months of Deadlock, WTO’s TRIPS Council Will Finally Discuss Intellectual Property Waiver Compromise 03/05/2022 Kerry Cullinan In a significant breakthrough, the World Trade Organization’s (WTO) TRIPS Council on Friday will finally discuss a compromise proposal on a waiver of intellectual property (IP) rights on COVID-19 vaccines – almost 18 months after it was first proposed by India and South Africa. Members attending an informal meeting of the TRIPS Council on Tuesday […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WTO Chief Hopes for “Workable Compromise” on TRIPS Waiver by June; US Signs Deal to Share COVID Vaccine Know-How with WHO 12/05/2022 Raisa Santos & Elaine Ruth Fletcher The United States National Institute of Health (NIH) has finalized an agreement with WHO’s COVID-19 patent sharing facility (C-TAP) to share the patent rights on 11 government-funded coronavirus medicine and vaccine technologies – in what is perhaps the most significant agreement to date with WHO to share closely-guarded pharma know-how. The announcement was made today […] Continue reading -> Moderna Seeks Dismissal in US Court of COVID-19 Vaccine Patent Infringement Lawsuit By Arbutus, Genevant 11/05/2022 Aishwarya Tendolkar Moderna has filed a brief in the United States District Court for the District of Delaware seeking the dismissal of a patent infringement lawsuit that pertains to the production and sale of its COVID-19 mRNA vaccine Spikevax. The lawsuit against the U.S-based pharmaceutical giant was filed by Arbutus Biopharma Corporation and Genevant Sciences, which had […] Continue reading -> After Months of Deadlock, WTO’s TRIPS Council Will Finally Discuss Intellectual Property Waiver Compromise 03/05/2022 Kerry Cullinan In a significant breakthrough, the World Trade Organization’s (WTO) TRIPS Council on Friday will finally discuss a compromise proposal on a waiver of intellectual property (IP) rights on COVID-19 vaccines – almost 18 months after it was first proposed by India and South Africa. Members attending an informal meeting of the TRIPS Council on Tuesday […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Moderna Seeks Dismissal in US Court of COVID-19 Vaccine Patent Infringement Lawsuit By Arbutus, Genevant 11/05/2022 Aishwarya Tendolkar Moderna has filed a brief in the United States District Court for the District of Delaware seeking the dismissal of a patent infringement lawsuit that pertains to the production and sale of its COVID-19 mRNA vaccine Spikevax. The lawsuit against the U.S-based pharmaceutical giant was filed by Arbutus Biopharma Corporation and Genevant Sciences, which had […] Continue reading -> After Months of Deadlock, WTO’s TRIPS Council Will Finally Discuss Intellectual Property Waiver Compromise 03/05/2022 Kerry Cullinan In a significant breakthrough, the World Trade Organization’s (WTO) TRIPS Council on Friday will finally discuss a compromise proposal on a waiver of intellectual property (IP) rights on COVID-19 vaccines – almost 18 months after it was first proposed by India and South Africa. Members attending an informal meeting of the TRIPS Council on Tuesday […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
After Months of Deadlock, WTO’s TRIPS Council Will Finally Discuss Intellectual Property Waiver Compromise 03/05/2022 Kerry Cullinan In a significant breakthrough, the World Trade Organization’s (WTO) TRIPS Council on Friday will finally discuss a compromise proposal on a waiver of intellectual property (IP) rights on COVID-19 vaccines – almost 18 months after it was first proposed by India and South Africa. Members attending an informal meeting of the TRIPS Council on Tuesday […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> Posts navigation Older postsNewer posts